{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:53:16Z","timestamp":1793364796875,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"DOI":"10.1038\/s41433-023-02442-x","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T14:05:53Z","timestamp":1675951553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The relationship between dry eye disease and anticholinergic burden"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-3221","authenticated-orcid":false,"given":"Zeynep","family":"Katipo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-7783","authenticated-orcid":false,"given":"Rafiye Nur","family":"Abay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"2442_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276\u201383.","journal-title":"Ocul Surf"},{"key":"2442_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","volume":"182","author":"KF Farrand","year":"2017","unstructured":"Farrand KF, Fridman M, Stillman I, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90\u20138.","journal-title":"Am J Ophthalmol"},{"key":"2442_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334\u201365.","journal-title":"Ocul Surf"},{"key":"2442_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","volume":"157","author":"AJ Paulsen","year":"2014","unstructured":"Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799\u2013806.","journal-title":"Am J Ophthalmol"},{"key":"2442_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/ICU.0b013e3283023d4c","volume":"19","author":"R Latkany","year":"2008","unstructured":"Latkany R. Dry eyes: Etiology and management. Curr Opin Ophthalmol. 2008;19:287\u201391.","journal-title":"Curr Opin Ophthalmol"},{"key":"2442_CR6","doi-asserted-by":"publisher","first-page":"102266","DOI":"10.1016\/j.npep.2022.102266","volume":"95","author":"K Asiedu","year":"2022","unstructured":"Asiedu K. Role of ocular surface neurobiology in neuronal-mediated inflammation in dry eye disease. Neuropeptides. 2022;95:102266.","journal-title":"Neuropeptides"},{"key":"2442_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.otc.2005.03.012","volume":"38","author":"JP Gilbard","year":"2005","unstructured":"Gilbard JP. The diagnosis and management of dry eyes. Otolaryngol Clin North Am. 2005;38:871\u201385.","journal-title":"Otolaryngol Clin North Am"},{"key":"2442_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"N Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A, Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol. 2007;17:341\u20139.","journal-title":"Eur J Ophthalmol"},{"key":"2442_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtos.2021.06.009","volume":"22","author":"LE Wolpert","year":"2021","unstructured":"Wolpert LE, Snieder H, Jansonius NM, Utheim TP, Hammond CJ, Vehof J. Medication use and dry eye symptoms: A large, hypothesis-free, population-based study in the Netherlands. Ocul Surf. 2021;22:1\u201312.","journal-title":"Ocul Surf"},{"key":"2442_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","volume":"67","author":"RM Santaella","year":"2007","unstructured":"Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007;67:75\u201393.","journal-title":"Drugs"},{"key":"2442_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1517\/14740338.2011.579899","volume":"10","author":"P Gerretsen","year":"2011","unstructured":"Gerretsen P, Pollock BG. Drugs with anticholinergic properties: A current perspective on use and safety. Expert Opin Drug Saf. 2011;10:751\u201365.","journal-title":"Expert Opin Drug Saf"},{"key":"2442_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","volume":"15","author":"C Belmonte","year":"2017","unstructured":"Belmonte C, Nichols JJ, Cox SM, Brock JA, Begley CG, Bereiter DA, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15:404\u201337.","journal-title":"Ocul Surf"},{"key":"2442_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","volume":"56","author":"ML Chew","year":"2008","unstructured":"Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Mahmoud RA, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56:1333\u201341.","journal-title":"J Am Geriatr Soc"},{"key":"2442_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/014107680009300903","volume":"93","author":"J Mintzer","year":"2000","unstructured":"Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93:457\u201362.","journal-title":"J R Soc Med"},{"key":"2442_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-015-0029-9","volume":"15","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: A systematic review. BMC Geriatr. 2015;15:1\u201314.","journal-title":"BMC Geriatr"},{"key":"2442_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65989-9","volume":"10","author":"N Cebron Lipovec","year":"2020","unstructured":"Cebron Lipovec N, Jazbar J, Kos M. Anticholinergic burden in children, adults and older adults in Slovenia: A nationwide database study. Sci Rep. 2020;10:9337.","journal-title":"Sci Rep"},{"key":"2442_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40266-012-0044-x","volume":"30","author":"L Pasina","year":"2013","unstructured":"Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale. Drugs Aging. 2013;30:103\u201312.","journal-title":"Drugs Aging"},{"key":"2442_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S1041610202008505","volume":"14","author":"D Aizenberg","year":"2002","unstructured":"Aizenberg D, Sigler M, Weizman A, Barak Y. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr. 2002;14:307\u201310.","journal-title":"Int Psychogeriatr"},{"key":"2442_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jamda.2016.07.012","volume":"17","author":"DL Vetrano","year":"2016","unstructured":"Vetrano DL, La Carpia D, Grande G, Casucci P, Bacelli T, Bernabei R, et al. Anticholinergic medication burden and 5-year risk of hospitalization and death in nursing home elderly residents with coronary artery disease. J Am Med Dir Assoc. 2016;17:1056\u20139.","journal-title":"J Am Med Dir Assoc"},{"key":"2442_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fphar.2020.00570","volume":"11","author":"K Graves-Morris","year":"2020","unstructured":"Graves-Morris K, Stewart C, Soiza RL, Taylor-Rowan M, Quinn TJ, Loke YK, et al. The prognostic value of anticholinergic burden measures in relation to mortality in older individuals: A systematic review and meta-analysis. Front Pharmacol. 2020;11:570.","journal-title":"Front Pharmacol"},{"key":"2442_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11096-020-01117-x","volume":"43","author":"M Lavrador","year":"2021","unstructured":"Lavrador M, Cabral AC, Figueiredo IV, Ver\u00edssimo MT, Castel-Branco MM, Fernandez-Llimos F. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients. Int J Clin Pharm. 2021;43:128\u201336.","journal-title":"Int J Clin Pharm"},{"key":"2442_CR22","doi-asserted-by":"publisher","first-page":"103885","DOI":"10.1016\/j.archger.2019.05.010","volume":"87","author":"G Lozano-Ortega","year":"2020","unstructured":"Lozano-Ortega G, Johnston KM, Cheung A, Wagg A, Campbell NL, Dmochowski RR, et al. A review of published anticholinergic scales and measures and their applicability in database analyses. Arch Gerontol Geriatr. 2020;87:103885.","journal-title":"Arch Gerontol Geriatr"},{"key":"2442_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1542-0124(11)70034-9","volume":"9","author":"J Wong","year":"2011","unstructured":"Wong J, Lan W, Ong LM, Tong L. Non-hormonal systemic medications and dry eye. Ocul Surf. 2011;9:212\u201326.","journal-title":"Ocul Surf"},{"key":"2442_CR24","first-page":"478","volume":"5","author":"N Li","year":"2012","unstructured":"Li N, Deng XG, He MF. Comparison of the Schirmer I test with and without topical anesthesia for diagnosing dry eye. Int J Ophthalmol. 2012;5:478\u201381.","journal-title":"Int J Ophthalmol"},{"key":"2442_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640\u201350.","journal-title":"Cornea"},{"key":"2442_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3414\/ME10-01-0022","volume":"50","author":"A Dogac","year":"2011","unstructured":"Dogac A, Yuksel M, Avcl A, Ceyhan B, H\u00fcl\u00fcr \u00dc, Eryllmaz Z, et al. Electronic health record interoperability as realized in the Turkish health information system. Methods Inf Med. 2011;50:140\u20139.","journal-title":"Methods Inf Med"},{"key":"2442_CR27","doi-asserted-by":"crossref","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health. 2008;4:311\u201320.","DOI":"10.2217\/1745509X.4.3.311"},{"key":"2442_CR28","first-page":"S142","volume":"61","author":"N Campbell","year":"2013","unstructured":"Campbell N, Maidment I, Fox C, Khan B, Boustani M. The 2012 update to the anticholinergic cognitive burden scale. J Am Geriatr Soc. 2013;61:S142\u20133.","journal-title":"J Am Geriatr Soc"},{"key":"2442_CR29","first-page":"373","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Clin Epidemiol. 1987;40:373\u201383.","journal-title":"J Clin Epidemiol"},{"key":"2442_CR30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245\u201351.","journal-title":"J Clin Epidemiol"},{"key":"2442_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jtos.2020.04.005","volume":"19","author":"J Vehof","year":"2021","unstructured":"Vehof J, Snieder H, Jansonius N, Hammond CJ. Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf. 2021;19:83\u201393.","journal-title":"Ocul Surf"},{"key":"2442_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","volume":"15","author":"JAP Gomes","year":"2017","unstructured":"Gomes JAP, Azar DT, Baudouin C, Efron N, Hirayama M, Horwath-Winter J, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15:511\u201338.","journal-title":"Ocul Surf"},{"key":"2442_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00228-016-2162-6","volume":"73","author":"H Wouters","year":"2017","unstructured":"Wouters H, van der Meer H, Taxis K. Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies. Eur J Clin Pharm. 2017;73:257\u201366.","journal-title":"Eur J Clin Pharm"},{"key":"2442_CR34","doi-asserted-by":"publisher","first-page":"e026391","DOI":"10.1136\/bmjopen-2018-026391","volume":"9","author":"SM Szabo","year":"2019","unstructured":"Szabo SM, Gooch K, Schermer C, Walker D, Lozano-Ortega G, Rogula B, et al. Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study. BMJ Open. 2019;9:e026391.","journal-title":"BMJ Open"},{"key":"2442_CR35","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3390\/jcm9072040","volume":"9","author":"M Kawashima","year":"2020","unstructured":"Kawashima M, Yamada M, Shigeyasu C, Suwaki K, Uchino M, Hiratsuka Y, et al. Association of systemic comorbidities with dry eye disease. J Clin Med. 2020;9:2040.","journal-title":"J Clin Med"},{"key":"2442_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ajo.2018.10.001","volume":"198","author":"R Dana","year":"2019","unstructured":"Dana R, Bradley JL, Guerin A, Pivneva I, Evans AM, Stillman I\u00d6. Comorbidities and prescribed medications in patients with or without dry eye disease: a population-based study. Am J Ophthalmol. 2019;198:181\u201392.","journal-title":"Am J Ophthalmol"},{"key":"2442_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/ICO.0000000000000657","volume":"35","author":"HC Roh","year":"2016","unstructured":"Roh HC, Lee JK, Kim M, Oh J-H, Chang M-W, Chuck RS, et al. Systemic comorbidities of dry eye syndrome: the Korean National Health and Nutrition Examination Survey V, 2010 to 2012. Cornea. 2016;35:187\u201392.","journal-title":"Cornea"},{"key":"2442_CR38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/jcm8091439","volume":"8","author":"M Heidari","year":"2019","unstructured":"Heidari M, Noorizadeh F, Wu K, Inomata T, Mashaghi A. Dry eye disease: emerging approaches to disease analysis and therapy. J Clin Med. 2019;8:1439.","journal-title":"J Clin Med"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02442-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02442-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02442-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T09:50:32Z","timestamp":1725616232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02442-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":38,"alternative-id":["2442"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02442-x","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}